CoreWeave plans to spend up to $23B in 2025 to meet AI demand from clients like Microsoft and OpenAI, raising investor ...

Nvidia (NVDA) stock climbs as a major AI partnership with Saudi Arabia and a $23 billion CoreWeave infrastructure plan drive ...

New York State has officially included a free community college plan in the enacted FY 2026 budget. The new program makes higher education more accessible for adult learners statewide. Governor Kathy ...

Disclaimer: The text below is an advertorial article that is not part of Cryptonews.com editorial content. While it has undergone editorial review to ensure quality and relevance, it may not reflect ...

These winning initiatives demonstrate what's possible when advanced AI is orchestrated with modern process platforms." North America Winners Gordon Food Service (GFS): A $23B+ food distributor ...

“This is just the beginning,” wrote WLFI on X. Cryptonews has covered the cryptocurrency industry topics since 2017, aiming to provide informative insights to our readers. Our journalists and analysts ...

As part of this plan, Novartis will open a $1.1 billion biomedical research innovation hub in San Diego, California. The complex, expected to open between 2028 and 2029, will provide advanced ...

Swiss pharmaceutical giant Novartis unveiled a $23B plan to expand its U.S. manufacturing footprint earlier this month. The company expects to build seven new facilities and upgrade others over ...

Investing into uncertainty: What if the assumptions behind Roche’s move don’t hold? Roche plans to invest $50 billion in the U.S. Understandable, given how important the U.S. market is.

Join us for expert analysis on the evolving mining and AI compute landscapes ... 3 hours ago THE MINING POD: Tether and Antalpha, Galaxy’s CoreWeave Expansion, OP_RETURN drama For this week ...

Besides, Novartis, Johnson & Johnson plans to spend $55 billion over four years on domestic manufacturing, research and technology. Merck announced plans to spend $1 billion on a vaccine ...

Besides, Novartis, Johnson & Johnson plans to spend $55 billion over four years on domestic manufacturing, research and technology. Merck announced plans to spend $1 billion on a vaccine manufacturing ...